All PlansCoverageLow impact
Automated Point-of-Care Nerve Conduction Tests
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Family Medicine, Internal Medicine +3 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a medical policy establishing coverage criteria for automated point-of-care nerve conduction tests. The policy provides background on various FDA-cleared devices and their intended uses for diagnosing conditions like carpal tunnel syndrome, diabetic peripheral neuropathy, and lumbosacral radiculopathy, but does not specify actual coverage determinations or billing requirements.
Action Required
Review the policy document to understand coverage criteria for automated point-of-care nerve conduction testing devices. Monitor for subsequent policy updates that may specify actual coverage decisions, prior authorization requirements, or billing guidelines for these services.